Exp Neurol, 2014 · DOI: 10.1016/j.expneurol.2014.05.022 · Published: November 1, 2014
This study explores the potential of Schwann cells (SCs) transplantation to treat spinal cord injury (SCI) in rats. SCs were genetically modified to express green fluorescent protein (GFP), allowing them to be easily tracked after transplantation. The study found that transplanted SCs survived remarkably well for up to 24 weeks after grafting into the injured spinal cord. They were able to proliferate, migrate along the central canal, and myelinate regenerated axons. Although the transplanted SCs showed promising survival and functionality, they did not result in significant behavioral improvements in the rats. This suggests that a combination of strategies may be needed to achieve meaningful functional regeneration after SCI.
SCs have the potential to be used in cell-based therapies for spinal cord injuries.
Combining SC transplantation with other strategies may be needed for significant functional recovery.
Consistent immunosuppression is needed for long-term survival of grafted SCs.